CLEVELAND, Ohio-- A Naperville, Illinois-based compounding pharmacy is recalling a long list of drugs shipped to medical offices and patients in six states because the drugs-- which are inhaled, injected or used as eye drops-- may not be sterile.
Martin Avenue Pharmacy is recalling its compounded sterile preparations because patients who use them may be at risk of infection. There have not yet been any reports of illness or injury, according to the company. The company has stopped production of sterile products "until further notice."
The recalled compounded sterile products, which include injectable solutions, ointments, powders, and eye drops, were shipped to medical professionals and patients in Ohio, Illinois, Wisconsin, Michigan, Florida, Alabama and Texas. A full list of recalled products is available here.
Compounding pharmacies, which make drug solutions and prescriptions "from scratch" for individual patients or customers, allow for customized medications, including adjustments in strength, dosage, flavor, and removal of allergens that may be found in mass-produced drugs.
Sterility issues at several compounding pharmacies have resulted in recalls, injuries and even deaths over the past few years, including a 2012 fungal meningitis outbreakcaused by non-sterile injections from the New England Compounding Center in Massachusetts. Those injections killed 63 people and sickened 749, with conditions ranging from abscesses to meningitis, according to the Centers for Disease Control and Prevention.
Anyone who has an affected product should stop using it and contact their pharmacy to return it, according to the FDA. For help, call Martin Avenue Pharmacy at 630-355-6400 or toll free 888-355-6492, Monday through Friday, 9 a.m. to 7 p.m. Central Time or by e-mail at info@martinavenue.com.
To report a medication side effect to the FDA's MedWatch program, submit a report online or call 1-800-332-1088.
No comments:
Post a Comment